Effect of Fetuin A in Hemodialysis Patients

The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00309426

Enrollment

300

Registered

2006-03-31

Start date

2001-03-31

Completion date

2006-03-31

Last updated

2006-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis, Malnutrition

Keywords

atherosclerosis

Brief summary

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Detailed description

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Interventions

None listed

Study design

Observational model

DEFINED_POPULATION

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

0 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Hemodialysis for at least 6 months

Exclusion criteria

* Disabled patients

Countries

Japan

Outcome results